$4.050
-0.059 (-1.46%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SBC Prediction & Forecast by Similar Chart Analysis
Alphio's SBC stock price prediction model matches the current SBC Medical Group Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.06 (+0.37%). The 1-week path is $4.12 (+1.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy SBC Medical Group Holdings Inc Stock?
SBC Medical Group Holdings Inc is a good buy right now due to its recent Q2 2026 earnings report showing a revenue increase of 13% year-over-year to $49 million, alongside a robust adjusted EBITDA growth of 32% to $20 million. The stock is currently priced at $4.05, which is significantly below the analyst's target price of $8, suggesting a potential upside of 97.5%. Additionally, the forward P/E ratio of 9.30 indicates that the stock is undervalued compared to its earnings potential. However, a risk to consider is the recent earnings surprise of -16.67%, which may indicate volatility in performance expectations.
SBC stock price ended at $4.05 on Friday, after losing -1.46%
SBC Medical Group Holdings Inc (SBC) last closed at $4.05, losing -1.46%. These facts feed the 1-day and 1-week SBC price prediction above.
Forecast Drivers
SBC Medical Group Holdings Inc (SBC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches SBC, ranked by similarity.
Seasonality analysis for SBC
Historically the probability of a positive August return for SBC is 31.75%. February offers the highest probability of a positive month at 55.17%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.